IP Library Granted Patent US 8,974,517
Granted Patent B2
US 8,974,517 · App. 14/257,839 · Granted Mar 10, 2015

Thermoelastic and superelastic NI-TI-W alloy

Inventors: Brian Lee Pelton (Mountain View, CA); John F. Boylan (Murrieta, CA)
Assignee: Abbott Cardiovascular Systems Inc.
A61F2/82A61F2/90A61F2/91A61F2/915A61L31/022A61L31/14A61L31/18C22C19/03C22F1/006A61F2/962A61F2002/91516A61F2002/91533A61F2002/91575A61F2210/0019A61L2400/16Y10S623/901Y10S623/90A61F2230/0013
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,974,517
App. No.
14/257,839
Granted
Mar 10, 2015
Kind
B2
Abstract

A radiopaque nitinol stent for implantation in a body lumen is disclosed. The stent is made from a superelastic alloy such as nickel-titanium or nitinol, and includes a ternary element including tungsten. The added tungsten in specified amounts improve the radiopacity of the nitinol stent comparable to that of a stainless steel stent of the same strut pattern coated with a thin layer of gold. Furthermore, the nitinol stent has improved radiopacity yet retains its superelastic and shape memory behavior and further maintains a thin strut/wall thickness for high flexibility.

Claims (44)

1. An endoprosthesis delivery system comprising:

a delivery sheath and an endoprosthesis disposed within the delivery sheath, the endoprosthesis comprising:

a tubular-shaped body, the body including a nickel-titanium superelastic alloy, and the alloy further includes a ternary element including tungsten, wherein the tubular-shaped body includes a nickel-titanium-tungsten tubing having an austenite finish temperature of −15 degrees C. to 0 degrees C.

2. The endoprosthesis delivery system of claim 1 , wherein the endoprosthesis delivery system is configured to be passed through a body lumen over a guidewire.

3. The endoprosthesis delivery system of claim 1 , wherein the atomic percent of the tungsten is greater than or equal to 5 and less than or equal to 12.

4. The endoprosthesis delivery system of claim 1 , wherein the atomic percent of the nickel is 50.8, the atomic percent of the tungsten is 10, and a balance is the atomic percent of titanium.

5. The endoprosthesis delivery system of claim 1 , wherein the superelastic alloy includes a stress-induced martensite phase.

6. The endoprosthesis delivery system of claim 1 , wherein the atomic percent of the nickel is 50.8 and the atomic percent of the titanium is a maximum of approximately 40.

7. The endoprosthesis delivery system of claim 1 , wherein an austenite finish temperature (A f ) of the superelastic alloy in the endoprosthesis is greater than or equal to zero and less than or equal to 30 degrees C.

8. The endoprosthesis delivery system of claim 1 , wherein the tubular-shaped body includes raw tubing having an austenite finish temperature (A f ) of greater than or equal to −15 degrees C. and less than or equal to 0 degrees C.

9. The endoprosthesis delivery system of claim 1 , wherein the endoprosthesis has a greater radiopacity than a 316L stainless steel endoprosthesis coated with 4.7 μm of gold.

10. An endoprosthesis delivery system comprising:

a delivery sheath;

a delivery catheter configured to be disposed within the delivery sheath; and

an endoprosthesis disposed adjacent to a distal end of the delivery catheter, the endoprosthesis comprising:

a tubular-shaped body wherein the body includes a nickel-titanium superelastic alloy with a ternary element including tungsten, said alloy exhibiting a stress-strain curve that approximates the idealized stress-strain curve of binary nickel-titanium, wherein the body is radiopaque and the tubular-shaped body includes a pattern with struts no greater than 0.0046 inch in width.

11. The endoprosthesis delivery system of claim 10 , wherein the atomic percent of the tungsten is greater than or equal to 5 and less than or equal to 12.

12. The endoprosthesis delivery system of claim 10 , wherein the atomic percent of the nickel is 50.8, the atomic percent of the tungsten is 10, and a balance is the atomic percent of titanium.

13. The endoprosthesis delivery system of claim 10 , wherein the superelastic alloy includes a stress-induced martensite phase.

14. The endoprosthesis delivery system of claim 10 , wherein the atomic percent of the nickel is 50.8 and the atomic percent of the titanium is a maximum of approximately 40.

15. The endoprosthesis delivery system of claim 10 , wherein the superelastic alloy in the tubular-shaped body has an austenite finish temperature (A f ) of greater than or equal to zero and less than or equal to 30 degrees C.

16. The endoprosthesis delivery system of claim 10 , wherein the tubular-shaped body includes raw tubing having an austenite finish temperature (A f ) of greater than or equal to −15 degrees C. and less than or equal to 0 degrees C.

17. An endoprosthesis delivery system comprising:

a delivery sheath;

a delivery catheter configured to be disposed within the delivery sheath; and

an endoprosthesis disposed on the deliver catheter, the endoprosthesis comprising:

a tubular-shaped body wherein the body includes a nickel-titanium superelastic alloy with a ternary element including tungsten, wherein the nickel-titanium superelastic alloy includes:

30 to 52 atomic percent titanium,

5 to 12 atomic percent tungsten, and

a balance of nickel;

wherein the tubular-shaped body is formed from a nickel-titanium-tungsten tubing having an austenite finish temperature (A f ) of −15 degree C. to 0 degree C., wherein the body is radiopaque.

18. The endoprosthesis delivery system of claim 17 , wherein the nickel-titanium superelastic alloy includes 50.8 atomic percent nickel, 10 atomic percent tungsten, and a balance of titanium.

19. The endoprosthesis delivery system of claim 17 , wherein the tubular-shaped body includes a strut pattern with struts no greater than 0.0046 inch in width.

20. The endoprosthesis delivery system of claim 17 , wherein the superelastic alloy includes a stress-induced martensite phase.

21. The endoprosthesis delivery system of claim 17 , wherein an austenite finish temperature (A f ) of the superelastic alloy in the tubular-shaped body of the endoprosthesis is greater than or equal to zero and less than or equal to 30 degrees C.

22. An endoprosthesis delivery system comprising:

a delivery sheath and an endoprosthesis disposed within the delivery sheath, the endoprosthesis comprising:

a tubular-shaped body including:

an atomic percent of nickel of 50.8,

an atomic percent of tungsten greater than or equal to 5 and less than or equal to 12, and

a balance of titanium

wherein the tubular-shaped body has an active austenite finish temperature A f defined by −15 degree C.≦active A f ≦0 degree C.

23. The endoprosthesis delivery system of claim 22 , wherein the tubular-shaped body includes 50.8 atomic percent nickel, 10 atomic percent tungsten, and a balance of titanium.

24. The endoprosthesis delivery system of claim 22 , wherein the tubular-shaped body includes a strut pattern having struts and each strut has a cross-sectional area of less than 0.000021 in 2 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2014
From: PELTON, BRIAN LEE
To: ADVANCED CARDIOVASCULAR SYSTEMS, INC.
Reel/Frame 032725/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2014
From: BOYLAN, JOHN F.
To: ABBOTT CARDIOVASCULAR SYSTEMS INC.
Reel/Frame 032725/0642 →
CHANGE OF NAME Recorded Apr 22, 2014
From: ADVANCED CARDIOVASCULAR SYSTEMS, INC.
To: ABBOTT CARDIOVASCULAR SYSTEMS INC.
Reel/Frame 032732/0833 →
Continuity (6)
Continuation 13773178 · Feb 21, 2013
Continuation 12685991 · Jan 12, 2010
Continuation 10917701 · Aug 13, 2004
Continuation 10406999 · Apr 3, 2003
Continuation 09752785 · Dec 28, 2000
Related Publication 20140243947A1 · Aug 28, 2014